Literature DB >> 30791998

Role of Preoperative Cardiovascular Magnetic Resonance in Planning Ventricular Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy.

Paolo Spirito1, Irene Binaco2, Daniele Poggio2, Aleksei Zyrianov2, Massimiliano Grillo2, Laura Pezzoli3, Jessica Rossi2, Dmitri Malanin2, Giuseppe Vaccari2, Lucian Dorobantu4, Maria Iascone3, Andrea Mortara2, Toufic Khouri2, Paolo Bruzzi5, Paolo Ferrazzi2.   

Abstract

In obstructive hypertrophic cardiomyopathy (HC), extreme heterogeneity of septal morphology makes septal myectomy particularly challenging. Although cardiovascular magnetic resonance (CMR) reconstructs ventricular anatomy with high spatial resolution, CMR is not used systematically to plan preoperatively septal myectomy. In this study, we report our results with using CMR to plan the extent of septal excision in 112 consecutive HC patients who subsequently underwent myectomy. Depth and length of the myectomy planned at CMR were compared with those of the septal muscle excised in a single piece in all patients. Anterior septum maximal thickness at CMR was 22 ± 5 mm and excised muscle thickness 9 ± 3 mm. Planned myectomy length was 35 ± 11 mm (range 17 to 65) and excised muscle length 38 ± 10 mm (range 10 to 70), indicating extension of septal resection to mid-cavity. Thickness and length of the planned myectomy showed a significant correlation with the excised muscle (R2 = 0.345; p <0.001; and R2 = 0.358; p <0.001, respectively). Deep septal crypts were identified at CMR in 12(11%) patients, preventing muscle excision from areas at increased risk of iatrogenic septal defect. Large aberrant muscle bundles that could decrease mid-cavity dimension were identified at CMR and excised in 26(23%) patients. In the 55 patients with postoperative CMR, qualitative comparison of pre and postoperative ventricular morphology showed a smooth and apically extended myectomy. In conclusion, CMR planning of septal myectomy provided high resolution images of septal morphology and allowed us to perform a standardized and apically extended septal excision that was associated with favorable outcome. Our novel approach could make myectomy more accessible to cardiovascular surgeons.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 30791998     DOI: 10.1016/j.amjcard.2019.01.041

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

Review 1.  Mitral Valve Disease in Hypertrophic Cardiomyopathy:Evaluation and Management.

Authors:  C Charles Jain; Darrell B Newman; Jeffrey B Geske
Journal:  Curr Cardiol Rep       Date:  2019-10-31       Impact factor: 2.931

2.  Mini-invasive surgical instruments in transaortic myectomy for hypertrophic obstructive cardiomyopathy: a single-center experience with 168 cases.

Authors:  Qiang Ji; Yu Lin Wang; Ye Yang; Hao Lai; Wen Jun Ding; Li Min Xia; Chun Sheng Wang
Journal:  J Cardiothorac Surg       Date:  2021-03-17       Impact factor: 1.637

Review 3.  Septal Ablation Versus Surgical Myomectomy for Hypertrophic Obstructive Cardiomyopathy.

Authors:  F Pelliccia; H Seggewiss; F Cecchi; P Calabrò; G Limongelli; O Alfieri; P Ferrazzi; M H Yacoub; I Olivotto
Journal:  Curr Cardiol Rep       Date:  2021-10-01       Impact factor: 2.931

4.  Septal myectomy with mitral valve surgery in patients after alcohol septal ablation.

Authors:  Kostiantyn V Rudenko; Vasyl V Lazoryshynets; Lidiia O Nevmerzhytska; Mariia O Tregubova; Polina A Danchenko
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-05-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.